Literature DB >> 4661095

Cellular immunity to human breast carcinoma.

G Fossati, S Canevari, G Della Porta, G P Balzarini, U Veronesi.   

Abstract

Entities:  

Mesh:

Year:  1972        PMID: 4661095     DOI: 10.1002/ijc.2910100221

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  9 in total

1.  Cellular immunity to breast carcinoma and malignant melanoma.

Authors:  A J Cochran; R M Mackie; C E Thomas; R M Grant; D E Cameron-Mowat; W G Spilg
Journal:  Br J Cancer Suppl       Date:  1973-08

2.  Immune responses to tumour and embryo cells in patients with mammary carcinoma.

Authors:  G Della Porta; S Canevari; G Fossati
Journal:  Br J Cancer Suppl       Date:  1973-08

Review 3.  Clinical value of tumour-associated antigens.

Authors:  A M Neville
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1974

4.  Immunobiology of operable breast cancer: an assessment of biologic risk by immunoparameters.

Authors:  H J Wanebo; P P Rosen; T Thaler; J A Urban; H F Oettgen
Journal:  Ann Surg       Date:  1976-09       Impact factor: 12.969

5.  Evaluation of leucocyte functions six years after tumour autograft in human mammary cancer.

Authors:  J M Anderson; F Kelly; S E Wood; K D Rodger; R I Freshney
Journal:  Br J Cancer Suppl       Date:  1973-08

6.  The relationship between cytotoxicity and prognostically significant histologic changes in lymph nodes from patients with cancer of the breast.

Authors:  I J Check; M Cobb; R L Hunter
Journal:  Am J Pathol       Date:  1980-02       Impact factor: 4.307

7.  Isolation of a protease from the cell-free medium of in vitro cultured mammary carcinoma.

Authors:  A A Hakim
Journal:  Experientia       Date:  1976-08-15

8.  Fc receptor-bearing peripheral blood mononuclear cells in breast cancer patients: a possible marker of tumour burden and prognosis.

Authors:  J Bray; T A McPherson
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

9.  Horizontal studies of cell mediated immune reactions to autologous tumour antigens in patients with operable mammary carcinoma.

Authors:  B M Jones; A R Turnbull
Journal:  Br J Cancer       Date:  1975-09       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.